Alzinova AB (OSTO:ALZ) Current Deferred Revenue : kr0.00 Mil (As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Alzinova AB's current deferred revenue for the quarter that ended in Sep. 2023 was kr0.00 Mil.

Alzinova AB Current Deferred Revenue Historical Data

The historical data trend for Alzinova AB's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB Current Deferred Revenue Chart

Alzinova AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Current Deferred Revenue

Get a 7-Day Free Trial

Alzinova AB Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Current Deferred Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Alzinova AB Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Alzinova AB's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Alzinova AB (OSTO:ALZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

78D:Germany

Address

Pepparedsleden 1, Molndal, SWE, SE-431 83

Website

https://www.alzinova.com

Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is also engaged in development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody. The product is in clinical development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB (OSTO:ALZ) Headlines

No Headlines